---
figid: PMC2808731__gm115-5
figlink: /pmc/articles/PMC2808731/figure/F5/
number: F5
caption: Overview of the key metabolic changes induced by PPARδ stimulation. (a) Metabolic
  pathways altered in PPARδ agonist treated mice liver. Metabolites increased relative
  to control tissue are in red; metabolites decreased relative to control tissue are
  in blue. (b) Linoleate pathway altered in PPARδ agonist treated mice liver. Metabolites
  increased relative to control tissue are in red; metabolites decreased relative
  to control tissue are in blue. (c) Linolenate pathway altered in PPARδ agonist treated
  mice liver. Metabolites increased relative to control tissue are in red; metabolites
  decreased relative to control tissue are in blue. (d) Metabolic pathways altered
  in PPARδ agonist treated mice skeletal muscle. Metabolites increased relative to
  control tissue are in red; metabolites decreased relative to control tissue are
  in blue.
pmcid: PMC2808731
papertitle: Increased hepatic oxidative metabolism distinguishes the action of Peroxisome
  proliferator-activated receptor δ from Peroxisome proliferator-activated receptor
  γ in the ob/ob mouse.
reftext: Lee D Roberts, et al. Genome Med. 2009;1(12):115-115.
pmc_ranked_result_index: '32491'
pathway_score: 0.8532851
filename: gm115-5.jpg
figtitle: Overview of the key metabolic changes induced by PPARD stimulation
year: '2009'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC2808731__gm115-5.html
  '@type': Dataset
  description: Overview of the key metabolic changes induced by PPARδ stimulation.
    (a) Metabolic pathways altered in PPARδ agonist treated mice liver. Metabolites
    increased relative to control tissue are in red; metabolites decreased relative
    to control tissue are in blue. (b) Linoleate pathway altered in PPARδ agonist
    treated mice liver. Metabolites increased relative to control tissue are in red;
    metabolites decreased relative to control tissue are in blue. (c) Linolenate pathway
    altered in PPARδ agonist treated mice liver. Metabolites increased relative to
    control tissue are in red; metabolites decreased relative to control tissue are
    in blue. (d) Metabolic pathways altered in PPARδ agonist treated mice skeletal
    muscle. Metabolites increased relative to control tissue are in red; metabolites
    decreased relative to control tissue are in blue.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - TMAO
  - Succinyl Co-A
  - Adenine
  - Methyithio-adenosine
  - Alanine
  - aldehyde
  - Arginine
  - Aspartate
  - Choline
  - Creatine
  - 13,16,19-Docosahexaenoic Acid
  - Fatty Acid
  - Fatty Acids
  - Fructose
  - Galactose
  - Glucose
  - Glutamine
  - Glycerol
  - Glycine
  - Hydroxybutyrate
  - Isocitrate
  - Isoleucine
  - Oxoglutarate
  - Linolenic Acid
  - Methionine
  - Oxaloacetate
  - Proline
  - Putrescine
  - Pyruvate
  - Succinate
  - Taurine
  - Threonine
  - Valine
  - 8,11,14-Eicosatrienoic acid
  - linolenate
  - Glutamate
  - Lactate
  - Linoleate
genes: []
chemicals:
- word: TMAO
  source: MESH
  identifier: C005855
- word: Succinyl Co-A
  source: MESH
  identifier: C012046
- word: Adenine
  source: MESH
  identifier: D000225
- word: Methyithio-adenosine
  source: MESH
  identifier: D000241
- word: Alanine
  source: MESH
  identifier: D000409
- word: aldehyde
  source: MESH
  identifier: D000447
- word: Arginine
  source: MESH
  identifier: D001120
- word: Aspartate
  source: MESH
  identifier: D001224
- word: Choline
  source: MESH
  identifier: D002794
- word: Creatine
  source: MESH
  identifier: D003401
- word: 13,16,19-Docosahexaenoic Acid
  source: MESH
  identifier: D004281
- word: Fatty Acid
  source: MESH
  identifier: D005227
- word: Fatty Acids
  source: MESH
  identifier: D005227
- word: Fructose
  source: MESH
  identifier: D005632
- word: Galactose
  source: MESH
  identifier: D005690
- word: Glucose
  source: MESH
  identifier: D005947
- word: Glutamine
  source: MESH
  identifier: D005973
- word: Glycerol
  source: MESH
  identifier: D005990
- word: Glycine
  source: MESH
  identifier: D005998
- word: Hydroxybutyrate
  source: MESH
  identifier: D006885
- word: Isocitrate
  source: MESH
  identifier: D007523
- word: Isoleucine
  source: MESH
  identifier: D007532
- word: Oxoglutarate
  source: MESH
  identifier: D007656
- word: Linolenic Acid
  source: MESH
  identifier: D008042
- word: Methionine
  source: MESH
  identifier: D008715
- word: Oxaloacetate
  source: MESH
  identifier: D010071
- word: Proline
  source: MESH
  identifier: D011392
- word: Putrescine
  source: MESH
  identifier: D011700
- word: Pyruvate
  source: MESH
  identifier: D011773
- word: Succinate
  source: MESH
  identifier: D013386
- word: Taurine
  source: MESH
  identifier: D013654
- word: Threonine
  source: MESH
  identifier: D013912
- word: Valine
  source: MESH
  identifier: D014633
- word: 8,11,14-Eicosatrienoic acid
  source: MESH
  identifier: D015126
- word: linolenate
  source: MESH
  identifier: D017962
- word: Glutamate
  source: MESH
  identifier: D018698
- word: Lactate
  source: MESH
  identifier: D019344
- word: Linoleate
  source: MESH
  identifier: D019787
diseases: []
figid_alias: PMC2808731__F5
redirect_from: /figures/PMC2808731__F5
figtype: Figure
---
